A detailed history of Premier Fund Managers LTD transactions in Repligen Corp stock. As of the latest transaction made, Premier Fund Managers LTD holds 4,113 shares of RGEN stock, worth $599,346. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,113
Holding current value
$599,346
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$123.41 - $160.92 $507,585 - $661,863
4,113 New
4,113 $592,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.